(CercleFinance.com) – Virbac announces the acquisition of Sasaeah, a major player in animal health in Japan.
According to Virbac, this strategic acquisition will bring the company a leading position in the livestock vaccine market in Japan, particularly in the cattle segment, and a broad portfolio of pharmaceutical products for all major species.
Resulting from the merger of two historic players in animal health (Fujita Pharmaceutical Co. Ltd. and Kyoto Biken Laboratories Inc.) under the aegis of ORIX Corporation, Sasaeah generates annual revenues of approximately 75 million euros, of which approximately 50% comes from vaccines.
The details and amount of the transaction were not specified.
Copyright © 2024 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends using the buttons below.
